Results 131 to 140 of about 42,901 (212)

Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas. [PDF]

Neuro Oncol
Arakawa Y, Saito R, Kanemura Y, Mishima K, Koriyama S, Narita Y, Kumabe T, Motomura K, Sugiyama K, Yamasaki F, Mukasa A, Kanamori M, Kuga D, Nagane M, Kakurai Y, Isobe K, Nakamura H.   +16 more
europepmc   +1 more source

Phase I/II and window-of-opportunity study of pamiparib and metronomic temozolomide for recurrent isocitrate dehydrogenase mutant gliomas. [PDF]

Neuro Oncol
Schiff D, Ye X, Li J, Ellingson BM, Wen PY, Walbert T, Campian J, Nabors LB, Ozer BH, Desai A, Omuro A, Desideri S, Danda N, Grossman S, Bindra RS.   +14 more
europepmc   +1 more source

Some properties of yeast isocitrate dehydrogenase [PDF]

Biochemical Journal, 1972
openaire   +2 more sources

Histopathological grading affects survival in patients with isocitrate dehydrogenase-wildtype gliomas. [PDF]

Front Oncol
Hou Z, Liu D, Hou Z, Zhang H, Wang H.
europepmc   +1 more source

Time-dependent diffusion-weighted imaging assessment of tumor grading and isocitrate dehydrogenase genotypes in adult-type diffuse gliomas. [PDF]

Jpn J Radiol
Kamimura K, Nakano T, Nakajo M, Kamizono J, Hasegawa T, Tobo D, Mukai A, Kamimura Y, Ejima F, Nagano H, Takumi K, Nakajo M, Higa N, Yonezawa H, Hanaya R, Kirishima M, Tanimoto A, Otsuka H, Hirahara D, Imai H, Feiweier T, Yoshiura T.   +21 more
europepmc   +1 more source

Isocitrate dehydrogenase 1 mutations drive downregulation of IL1R1 and dysregulated inflammatory response in acute myeloid leukemia. [PDF]

Blood Cancer J
Steinhäuser S, Beder T, Hübner E, Feuereisel DS, Jebens J, Wolgast N, Karaca MB, Richter K, Hedemann N, Steer B, Denker M, Bendig S, Brüggemann M, Silva P, Fransecky L, Neumann M, Stölzel F, Hartmann AM, Gemoll T, Bastian L, Baldus CD, Lipinski S.   +21 more
europepmc   +1 more source

Reliable cognitive changes the first year following guideline-based treatment of isocitrate dehydrogenase mutated gliomas: A longitudinal multicenter study. [PDF]

Neuro Oncol
Rydén I, Latini F, Alberius Munkhammar Å, Hellström P, Neimantaite A, Lycett A, Harba D, Carstam L, Blomstrand M, Zetterling M, Smits A, Jakola AS.   +11 more
europepmc   +1 more source

ON THE MECHANISM OF THE ACONITASE AND ISOCITRIC DEHYDROGENASE REACTIONS

Journal of Biological Chemistry, 1957
S, ENGLARD, S P, COLOWICK
openaire   +2 more sources